Abstract
Plakoglobin (γ-catenin) is a homolog of β-catenin with similar dual adhesive and signaling functions. The adhesive function of these proteins is mediated by their interactions with cadherins, whereas their signaling activity is regulated by association with various intracellular partners. In this respect, β-catenin has a well-defined oncogenic activity through its role in the Wnt signaling pathway, whereas plakoglobin acts as a tumor/metastasis suppressor through mechanisms that remain unclear. We previously expressed plakoglobin in SCC9 squamous carcinoma cells (SCC9-P) and observed a mesenchymal-to-epidermoid transition. Comparison of the protein and RNA profiles of parental SCC9 cells and SCC9-P transfectants identified various differentially expressed proteins and transcripts, including the nonmetastatic protein 23 (Nm23). In this study, we show that Nm23-H1 mRNA and Nm23-H2 protein are increased after plakoglobin expression. Coimmunoprecipitation and confocal microscopy studies using SCC9-P and various epithelial cell lines with endogenous plakoglobin expression revealed that Nm23 interacts with plakoglobin, cadherins and α-catenin. Furthermore, Nm23-H2 is the primary isoform involved in these interactions, which occur prominently in the cytoskeleton-associated pool of cellular proteins. In addition, we show that plakoglobin–Nm23 interaction requires the N-terminal (α-catenin interacting) domain of plakoglobin. Our data suggest that by increasing the expression and stability of Nm23, plakoglobin has a role in regulating the metastasis suppressor activity of Nm23, which may further provide a potential mechanism for the tumor/metastasis suppressor function of plakoglobin itself.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arnaud-Dabernat S, Masse K, Smani M, Peuchant E, Landry M, Bourbon PM et al. (2004). Nm23-M2/NDP kinase B induces endogenous c-myc and nm23-M1/NDP kinase A overexpression in BAF3 cells. Both NDP kinases protect the cells from oxidative stress-induced death. Exp Cell Res 301: 293–304.
Ayabe T, Tomita M, Matsuzaki Y, Ninomiya H, Hara M, Shimizu T et al. (2004). Micrometastasis and Expression of nm23 Messenger RNA of Lymph Nodes from Lung Cancer and the Postoperative Clinical Outcome. Ann Thorac Cardio Surg 10: 152–159.
Bago R, Pavelić J, Vlahoviček GM, Bosnar MH . (2009). Nm23-H1 promotes adhesion of CAL 27 cells in vitro. Mol Carcinog 48: 779–789.
Benjamin JM, Nelson WJ . (2008). Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis. Semin Cancer Biol 18: 53–64.
Ben-Ze'ev A, Geiger B . (1998). Differential molecular interactions of β−catenin and plakoglobin in adhesion, signaling and cancer. Curr Opin Cell Biol 10: 629–639.
Bosnar MH, de Gunzburg J, Bago R, Brecevic L, Weber I, Pavelic J . (2004). Subcellular localization of A and B Nm23/NDPK subunits. Exp Cell Res 298: 275–284.
Bosnar MH, Bago R, Cetkovic H . (2009). Subcellular localization of Nm23/NDPK A and B isoforms: a reflection of their biological function? Mol Cell Biochem 329: 63–71.
Che G, Chen J, Liu L, Wang Y, Li L, Qin Y et al. (2006). Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981. Neoplasma 53: 530–537.
Chen XF, Zhang HT, Qi QY, Sun MM, Tao LY . (2005). Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China. Lung Cancer 48: 69–76.
Chidgey M, Dawson C . (2007). Desmosomes: a role in cancer? Br J Cancer 96: 1783–1787.
Daniel JM, Reynolds AB . (1995). The Tyrosine Kinase Substrate p120cas Binds Directly to E-Cadherin but Not to the Adenomatous Polyposis Coli Protein or α-Catenin. Mol Cell Biochem 15: 4819–4824.
Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI . (2005). Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell 123: 903–915.
Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J . (2003). Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 112: 659–672.
Garrod D, Chidgey M . (2008). Desmosome structure, composition and function. Biochim Biophys Acta 1778: 572–587.
Garrod D, Kimura TE . (2008). Hyper-adhesion: a new concept in cell-cell adhesion. Biochem Soc Trans 36: 195–201.
Gavert N, Ben-Ze'ev A . (2007). β−catenin signaling in biological control and cancer. J Cell Biochem 102: 820–828.
Green KJ, Simpson CL . (2007). Desmosomes: new perspectives on a classic. J Invest Dermatol 127: 2499–2515.
Hartsock A, Nelson WJ . (2008). Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 1778: 660–669.
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512.
Holthofer B, Windoffer R, Troyanovsky S, Leube RE . (2007). Structure and function of desmosomes. Int Rev Cytol 264: 65–163.
Huang H, He X . (2008). Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol 20: 119–125.
Huber O, Weiske J . (2008). Beta-catenin takes a HIT. Cell Cycle 7: 1326–1331.
Igawa M, Rukstalis DB, Tanabe T, Chodak GW . (1994). High levels of nm23 expression are related to cell proliferation in human prostate cancer. Cancer Res 54: 1313–1318.
Jeanes A, Gottardi CJ, Yap AS . (2008). Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27: 6920–6929.
Ji C, Li L, Gebre M, Pasdar M, Li L . (2005). Identification and quantification of differentially expressed proteins in E-cadherin deficient SCC9 cells and SCC9 transfectants expressing E-cadherin by dimethyl isotope labeling, LC-MALDI MS and MS/MS. J Proteome Res 4: 1419–1426.
Jin L, Liu G, Zhang CH, Lu CH, Xiong S, Zhang MY et al. (2009). Nm23-H1 regulates the proliferation and differentiation of the human chronic myeloid leukemia K562 cell line: A functional proteomics study. Life Sci 84: 458–467.
Jin T, George Fantus I, Sun J . (2008). Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin. Cell Signal 20: 1697–1704.
Jung S, Paek YW, Moon KS, Wee SC, Ryu HH, Jeong YI et al. (2006). Expression of Nm23 in gliomas and its effect on migration and invasion in vitro. Anticancer Res 26: 249–258.
Kanazawa Y, Ueda Y, Shimasaki M, Katsuda S, Yamamoto N, Tomita K et al. (2008). Down-regulation of plakoglobin in soft tissue sarcoma is associated with a higher risk of pulmonary metastasis. Anticancer Res 28: 655–664.
Khan MH, Yasuda M, Higashino F, Haque S, Kohgo T, Nakamura M et al. (2001). nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Am J Pathol 158: 1785–1791.
Kim HD, Youn B, Kim TS, Kim SH, Shin HS, Kim J . (2009). Regulators affecting the metastasis suppressor activity of Nm23-H1. Mol Cell Biochem 329: 167–173.
Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR et al. (2000). g-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of b-catenin. Genes Dev 14: 1319–1331.
Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO . (2000). The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 32: 247–258.
Lam L, Hu X, Aktary Z, Andrews DW, Pasdar M . (2009). Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha. Breast Cancer Res Treat 118: 605–621.
Lee HY, Lee H . (1999). Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity. Cancer Lett 145: 93–99.
Lee MY, Jeong WJ, Oh JW, Choi KY . (2009). NM23H2 inhibits EGF- and Ras-induced proliferation of NIH3T3 cells by blocking the ERK pathway. Cancer Lett 275: 221–226.
Li L, Chapman K, Hu H, Wong A, Pasdar M . (2007). Modulation of the oncogenic potential of beta−catenin by the subcellular localization of plakoglobin. Mol Carcinog 46: 824–838.
Li Z, Gallin W, Lauzon G, Pasdar M . (1998). L-CAM expression induces fibroblast-epidermoid transition in squamous carcinoma cells and down regulates the endogenous N-cadherin. J Cell Sci 111: 1005–1019.
MacDonald NJ, De La Rosa A, Benedict MA, Freije JMP, Jrutsch H, Steeg PS . (1993). A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem 268: 25780–25789.
McDermott WG, Boissan M, Lacombe ML, Steeg PS, Horak CE . (2008). Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth. Clin Exp Metastasis 25: 131–138.
Miyazaki H, Fukuda M, Ishijima Y, Takagi Y, Iimura T, Negishi A et al. (1999). Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture. Clin Cancer Res 5: 4301–4307.
Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB . (1993). Reduction of E-cadherin levels and deletion of the A-catenin gene in human prostate cancer cells. Cancer Res 53: 3585–3590.
Nakanishi K, Kumaki F, Hiroi S, Mukai M, Ikeda E, Kawai T . (2006). Mre11 expression in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Arch Pathol Lab Med 130: 1330–1334.
Narkio-Makela M, Pukkila M, Lagerstedt E, Virtaniemi J, Pirinen R, Johansson R et al. (2009). Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 135: 1035–1040.
Nelson WJ . (2008). Regulation of cell-cell adhesion by the cadherin-catenin complex. Biochem Soc Trans 36: 149–155.
Niessen CM, Gottardi CJ . (2008). Molecular components of the adherens junction. Biochim Biophys Acta 1778: 562–571.
Palacios F, Schweitzer JK, Boshans RL, D'Souza-Schorey C . (2002). ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat Cell Biol 4: 929–936.
Pantel K, Passlick B, Vogt J, Stosiek P, Angstwurm M, Seen-Hibler R et al. (1998). Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer. J Clin Oncol 16: 1407–1413.
Parker HR, Li Z, Sheinin H, Lauzon GJ, Pasdar M . (1998). Plakoglobin induces desmosome formation and epidermoid phenotype in N-cadherin-expressing squamous carcinoma cells deficient in plakoglobin and E-cadherin. Cell Motil Cytoskeleton 40: 87–100.
Pasdar M, Li Z, Chlumecky V . (1995). Plakoglobin: kinetics of synthesis, phosphorylation, stability, and interactions with desmoglein and E-cadherin. Cell Motil Cytoskeleton 32: 258–272.
Pasdar M, Nelson WJ . (1988a). Kinetics of desmosome assembly in Madin-Darby canine kidney epithelial cells: temporal and spatial regulation of desmoplakin organization and stabilization upon cell-cell contact. I. Biochemical analysis. J Cell Biol 106: 677–685.
Pasdar M, Nelson WJ . (1988b). Kinetics of desmosome assembly in Madin-Darby canine kidney epithelial cells: temporal and spatial regulation of desmoplakin organization and stabilization upon cell-cell contact. II. Morphological analysis. J Cell Biol 106: 687–695.
Peifer M, McCrea PD, Green KJ, Wieschaus E, Gumbiner BM . (1992). The vertebrate adhesive junction proteins beta-catenin and plakoglobin and the Drosophila segment polarity gene armadillo form a multigene family with similar properties. J Cell Biol 118: 681–691.
Perez-Moreno M, Fuchs E . (2006). Catenins: keeping cells from getting their signals crossed. Dev Cell 11: 601–612.
Postel EH, Berberich SJ, Rooney JW, Kaetzel DM . (2000). Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. J Bioen Biomem 32: 277–284.
Reiger-Christ KM, Ng L, Hanley RS, Durrani O, Ma H, Yee AS . (2005). Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential. Br J Cancer 92: 2153–2159.
Sacco PA, McGranahan TM, Wheelock MJ, Johnson KR . (1995). Identification of plakoglobin domains required for association with N-cadherin and α-catenin. J Biol Chem 270: 20201–20206.
Schuldiner O, Shor S, Benvenisty N . (2002). A computerized database-scan to identify c-MYC targets. Gene 292: 91–99.
Simcha I, Geiger B, Yehuda-Levenberg S, Salomon D, Ben-Ze'ev A . (1996). Suppresion of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin. J Cell Biol 133: 199–209.
Simcha I, Shtutman M, Salomon D, Zhurinsky J, Sadot E, Geiger B et al. (1998). Differential nuclear translocation and transactivation potential of β−catenin and plakoglobin. J Cell Biol 141: 1433–1448.
Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME . (1998). Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res 48: 6550–6554.
Steeg PS, Horak CE, Miller KD . (2008). Clinical-translational approaches to the Nm23-H1 metastasis suppressor. Clin Cancer Res 14: 5006–5012.
Steeg PS, Ouatas T, Halverson D, Palmieri D, Salermo M . (2003). Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 4: 51–62.
Stemmler MP . (2008). Cadherins in development and cancer. Mol Biosyst 4: 835–850.
Suzuki E, Ota S, Tsukuda K, Okita A, Matsuoka K, Murakami M et al. (2004). nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation. Int J Cancer 108: 207–211.
Syed V, Mukherjee K, Lyons-Weiler J, Lau KM, Mashima T, Tsuruo T et al. (2005). Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene 24: 1774–1787.
Tee YT, Chen GD, Lin LY, Ko JL, Wang PH . (2006). Nm23-H1: a metastasis-associated gene. Taiwan J Obstet Gynecol 45: 107–113.
Torlakovic E, Lilleby W, Torlakovic G, Fosså SD, Chibbar R . (2002). Prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score. Hum Pathol 33: 646–651.
van Roy F, Berx G . (2008). The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65: 3756–3788.
Wagner PD, Steeg PS, Vu ND . (1997). Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity. Proc Natl Acad Sci USA 94: 9000–9005.
Winn RA, Bremnes RM, Bemis L, Franklin WA, Miller YE, Cool C et al. (2002). γ-catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 21: 7497–7506.
Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ . (2005). Deconstructing the cadherin-catenin-actin complex. Cell 123: 889–901.
Zhurinsky J, Shtutman M, Ben-Ze'ev A . (2000a). Differential mechanisms of LEF/TCF family-dependent transcriptional activation by β−catenin and plakoglobin. Mol Cell Biol 20: 4238–4252.
Zhurinsky J, Shtutman M, Ben-Ze'ev A . (2000b). Plakoglobin and β−catenin: protein interactions, regulation and biological roles. J Cell Sci 113: 3127–3139.
Acknowledgements
This work is supported by the Alberta Cancer Research Institute and the Canadian Breast Cancer Foundation—Prairies/NWT Chapter (MP) and Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarships award (ZA). LL is supported by the Canadian Research Chairs Program. JM is supported by the Alberta Cancer Research Institute and Alberta Cancer Foundation. ZA currently holds a Killam Doctoral Award.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Rights and permissions
About this article
Cite this article
Aktary, Z., Chapman, K., Lam, L. et al. Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1. Oncogene 29, 2118–2129 (2010). https://doi.org/10.1038/onc.2009.495
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2009.495
Keywords
This article is cited by
-
Activation of Nm23-H1 to suppress breast cancer metastasis via redox regulation
Experimental & Molecular Medicine (2021)
-
Quassinoid analogs with enhanced efficacy for treatment of hematologic malignancies target the PI3Kγ isoform
Communications Biology (2020)
-
The NDPK/NME superfamily: state of the art
Laboratory Investigation (2018)
-
Small molecule activator of Nm23/NDPK as an inhibitor of metastasis
Scientific Reports (2018)
-
Desmosome regulation and signaling in disease
Cell and Tissue Research (2015)